Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis.
Ribbon Biolabs is a startup company based in Vienna, Austria, developing a new technology to synthesize large volumes of large and/or complex DNA molecules. Our team comprises 5 highly competent scientists of varied expertise and an experienced Project Manager.
Ribbon Biolabs is a startup company based in Vienna, Austria, developing a new technology to synthesize large volumes of large and/or complex DNA molecules. Our team comprises 5 highly competent scientists of varied expertise and an experienced Project Manager.
Location: Austria, Vienna
Employees: 11-50
Total raised: $25M
Founded date: 2018
Investors 2
| Date | Name | Website |
| 08.02.2022 | Hadean Ven... | hadeanvent... |
| - | IST Cube | ist-cube.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.02.2022 | Series A | $25M | - |
Mentions in press and media 8
| Date | Title | Description |
| 21.12.2023 | Hadean Ventures announces oversubscribed final close of Hadean Capital II | Hadean Ventures announces oversubscribed final close of Hadean Capital II – a fund dedicated to investments in life science start-ups across Europe Oslo, 21 December 2023. Hadean Ventures announced today the final close of Hadean Capital I... |
| 08.12.2023 | Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer | Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar named an advisor and board member. Vienna, Austria, December 6, 2023 – Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board... |
| 07.11.2023 | Life sciences in Austria: Innovation moves mountains | Setting up the startup phase, applying for funding, finding employees and investors, thinking through forms of financing, developing business models, opening up sales markets and so on — a lot of steps are necessary to go from an idea to a ... |
| 04.01.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 4th January 2023 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 03.01.2023 | Ribbon Biolabs Reaches Key Milestone with Automation of InfiniSynth Platform for Commercial-scale, Unlimited Length DNA Synthesis | Ribbon Biolabs, the DNA synthesis company, announced the successful implementation of their innovative InfiniSynth platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this milestone in collaboratio... |
| 31.01.2022 | Ribbon Biolabs raises EUR 18 million in its Series A financing | VIENNA, AUSTRIA, January 31, 2022 — Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and... |
| 31.01.2022 | Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology | Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Part... |
| 31.01.2022 | Ribbon Biolabs Raises EUR18M in Series A Financing | Ribbon Biolabs, a Vienna, Austria-based DNA synthesis company, closed EUR 18m in its Series A funding. The round was led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed inve... |